Trials / Enrolling By Invitation
Enrolling By InvitationNCT06345443
NRM on Vascular Perfusion in Healthy Adults
The Effect of Oral Nicotinamide Riboside on Systemic Vascular Perfusion in Healthy Adults: A Critical Foundation of Cerebrovascular Health, Cardiovascular Health, and Healthy Aging
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 35 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to better understand the effects of nicotinamide riboside supplement in overall cardiovascular health in healthy adults.
Detailed description
This study is a randomized, double-blind, placebo-controlled, parallel-dose clinical trial. Participants will be randomly assigned to one of three groups. Study measurements will be completed at three timepoints and intervention taken daily throughout the subject's 12 weeks of participation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Nicotinamide Riboside Malate | Active supplement. |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2024-11-25
- Primary completion
- 2026-09-30
- Completion
- 2026-12-31
- First posted
- 2024-04-03
- Last updated
- 2026-03-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06345443. Inclusion in this directory is not an endorsement.